Tech Company Financing Transactions

Proteostasis Therapeutics Funding Round

On 9/9/2015, Proteostasis Therapeutics landed $37 million in Series B funding from Cormorant Asset Management, F-Prime Capital and HealthCare Ventures.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
The company plans to use the proceeds of this financing to advance its lead product candidate in cystic fibrosis into human clinical studies and continue to expand its product portfolio.

Company Information

Company Status
Mailing Address
80 Guest St. 5th Floor
Boston, MA 02135
Email Address
Proteostasis Therapeutics (NASDAQ: PTI) is discovering and developing novel small molecule therapeutics designed to control the body's Proteostasis Network, which maintains the body's natural protein homeostasis to protect us from numerous diseases.
Proteostasis Therapeutics LinkedIn Company Profile
Social Media
Proteostasis Therapeutics Company Twitter Account
Company News
Proteostasis Therapeutics News
Proteostasis Therapeutics on Facebook
Proteostasis Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
Meenu Chhabra
  Meenu Chhabra LinkedIn Profile  Meenu Chhabra Twitter Account  Meenu Chhabra News  Meenu Chhabra on Facebook
Chief Medical Officer
Po-Shun Lee
  Po-Shun Lee LinkedIn Profile  Po-Shun Lee Twitter Account  Po-Shun Lee News  Po-Shun Lee on Facebook
Chief Operating Officer
Marija Zecevic
  Marija Zecevic LinkedIn Profile  Marija Zecevic Twitter Account  Marija Zecevic News  Marija Zecevic on Facebook
Chief Scientific Officer
Ben Munoz
  Ben Munoz LinkedIn Profile  Ben Munoz Twitter Account  Ben Munoz News  Ben Munoz on Facebook
VP - Bus. Development
Geoffrey Gilmartin
  Geoffrey Gilmartin LinkedIn Profile  Geoffrey Gilmartin Twitter Account  Geoffrey Gilmartin News  Geoffrey Gilmartin on Facebook
VP - Operations
Sheila Wilson
  Sheila Wilson LinkedIn Profile  Sheila Wilson Twitter Account  Sheila Wilson News  Sheila Wilson on Facebook



Browse more venture capital transactions:

Prev: 9/9/2015: Eden venture capital transaction
Next: 9/9/2015: Loci Controls venture capital transaction


Share this article


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary